Delivery Order SPE2DB22D2211-SPE2DB24FPGV5

Award Date 9/4/24
Potential Completion Date 9/25/24
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Globulin Tetanus Immune (IVIG) products. The $1,512.00 firm fixed price contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of OCTAGAM 10% VIAL 300ML, a pharmaceutical product. The contract has a ceiling value of $2,245.74 and is a firm fixed-price arrangement. The ultimate completion date for this delivery order is August 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major supplier of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,512.84 firm fixed price delivery order is for the provision of OCTAGAM 10% VIAL 300ML, a pharmaceutical product, with a completion date of May 31, 2024. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 20 gram/200 ML vials. The contract has a ceiling value of $23,825.00 and is set to run through October 31, 2024. The contract does not have a set-aside designation. As a leading supplier of pharmaceutical products and medical supplies to the U.S. federal government, AmerisourceBergen holds several Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.92 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400 ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,959.30 firm-fixed-price delivery order is for the supply of 4565940898 GAMUNEX-C 5 gram/50 milliliter vials. This contract has an ultimate completion date of October 17, 2024 and is not associated with any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,657.56 firm fixed price contract is for the delivery of 400 ml vials of the drug GAMUNEX-C, with a completion date of November 21, 2023. The award is not set aside for a specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,325.64 firm fixed-price delivery order is for the supply of GAMUNEX-C 10 gram/100 ml vials and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, a pharmaceutical product. The contract has a firm fixed price of $18,034.20 and a period of performance through October 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 20 gram/200 ml vials. The $44,366.76 fixed-price contract has a period of performance through December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPGV5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Octagam 10% intravenous immunoglobulin (IVIG) vials. The contract has a ceiling value of $8,982.96 and a completion date of September 25, 2024. This award is not associated with a set-aside program. AmerisourceBergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, vaccines, and medical supplies, to various government agencies and healthcare programs. The company has significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation for delivering a comprehensive range of pharmaceutical and medical products to support military treatment facilities, veteran hospitals, and other federal healthcare providers nationwide.

Generated 12/4/24, 9:54 AM